Article info

Download PDFPDF

Research paper
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme

Authors

  1. Correspondence to Dr Jacqueline Palace, Clinical Neurology, The Oxford University Hospitals Trust, Oxford OX3 9DU, UK; jacqueline.palace{at}ndcn.ox.ac.uk
View Full Text

Citation

Palace J, Duddy M, Lawton M, et al
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme

Publication history

  • Received March 6, 2018
  • Revised June 14, 2018
  • Accepted July 7, 2018
  • First published September 21, 2018.
Online issue publication 
February 14, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.